TWiV 808: Clinical update #81 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #81, Daniel Griffin discusses vaccine boosters, vaccination during pregnancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and anticoagulation regimens.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Pfizer phase III results in 5-11 year olds (Pfizer)
- FDA authorizes booster (FDA)
- V-safe vaccine pregnancy registry (CDC)
- High antibody levels in cord blood (Am J Ob Gyn)
- mRNA vaccines compared (MMWR)
- Effectiveness of single shot J&J (medRxiv)
- J&J booster results (J&J)
- EUA expansion for Lilly mAbs (Lilly)
- Remdesivir reduces hospitalization risk (Gilead)
- DisCoVeRy on Remdesivir (Lancet)
- Prophylactic anticoagulant dosing (Eur Heart J)
- Letters read on TWiV 808
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology